Cytokine and Gene Expression Profiling in Patients with HFE-Associated Hereditary Hemochromatosis according to Genetic Profile

Abstract

<b><i>Background:</i></b> Hemochromatosis gene (<i>HFE</i>)-associated hereditary hemochromatosis (HH) is characterized by downregulation of hepcidin synthesis, leading to increased intestinal iron absorption. <b><i>Objectives:</i></b> The objectives were to characterize and elucidate a possible association between gene expression profile, hepcidin levels, disease severity, and markers of inflammation in <i>HFE</i>-associated HH patients. <b><i>Methods:</i></b> Thirty-nine <i>HFE</i>-associated HH patients were recruited and assigned to 2 groups according to genetic profile: C282Y homozygotes in 1 group and patients with H63D, as homozygote or in combination with C282Y, in the other group. Eleven healthy first-time blood donors were recruited as controls. Gene expression was characterized from peripheral blood cells, and inflammatory cytokines and hepcidin-25 isoform were quantified in serum. Biochemical disease characteristics were recorded. <b><i>Results:</i></b> Elevated levels of interleukin 8 were observed in a significant higher proportion of patients than controls. In addition, compared to controls, gene expression of ζ-globin was significantly increased among C282Y homozygote patients, while gene expression of matrix metalloproteinase 8, and other neutrophil-secreted proteins, was significantly upregulated in patients with H63D. <b><i>Conclusion:</i></b> Different disease signatures may characterize HH patients according to their <i>HFE</i> genetic profile. Studies on larger populations, including analyses at protein level, are necessary to confirm these findings.